Metraipolis › archive › dc_c2125c8fe65a
OPTIMISE-ing consent in clinical trials: recommendations for designing accessible consent processes to address communication and decision-making needs as a… — Europe PMC PPR:PPR1278084
- Source
- Europe PMC
- Original
- https://europepmc.org/article/PPR/PPR1278084
- DOI
- 10.21203/rs.3.rs-9990455/v1
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T07:50:42.490Z
- SHA-256 of the archived text
12e479619e60f637271982b7cdee1fb37f135fc836161ddcde2a024a2d36a483- Stable URL of this page
https://metraipolis.com/documento/dc_c2125c8fe65a
How to cite
OPTIMISE-ing consent in clinical trials: recommendations for designing accessible consent processes to address communication and decision-making needs as a… — Europe PMC PPR:PPR1278084 — Europe PMC, https://europepmc.org/article/PPR/PPR1278084 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2125c8fe65a (Metraipolis archive dc_c2125c8fe65a, sha256 12e479619e60f637271982b7cdee1fb37f135fc836161ddcde2a024a2d36a483)
BibTeX
@misc{dcc2125c8fe65a,
title = {OPTIMISE-ing consent in clinical trials: recommendations for designing accessible consent processes to address communication and decision-making needs as a… — Europe PMC PPR:PPR1278084},
howpublished = {Europe PMC},
url = {https://europepmc.org/article/PPR/PPR1278084},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2125c8fe65a; sha256 12e479619e60f637271982b7cdee1fb37f135fc836161ddcde2a024a2d36a483},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR1278084. Agents can read the archived copy with the MCP tool read_document.